Gene · 10733
Papers2,106
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,106
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Investigating the Mechanisms of Pazopanib-induced Hepatotoxicity: Insights from Network Toxicology, Microarray Analysis, and Machine Learning. | Curr Med Chem | 2026 | 40417760 | PubTator, text mining | PubMed |
| Liver fibrosis in biliary atresia: identification of the key gene EDIL3 via integrated bioinformatics. | Front Med (Lausanne) | 2025 | 41647012 | PubTator, text mining | PubMed |
| Polo-like kinase 4: A molecular linchpin in cancer and its management. | iScience | 2025 | 41488365 | PubTator, text mining | PubMed |
| Identification of Critical Hub Genes and Pathways Regulating Chemotherapy Responses in Triple-Negative Breast Cancer: An Integrated Analysis. | Cell Biochem Funct | 2025 | 41392640 | PubTator, text mining | PubMed |
| Discovery of Potent, Selective and Efficacious Aminopyrazole Inhibitors of PLK4. | J Med Chem | 2025 | 41329867 | PubTator, text mining | PubMed |
| RETRACTION: Comparison of Expression Optimization of New Derivative of staphylokinase (SAK-2RGD-TTI) with the rSAK. | Biotechnol Prog | 2025 | 41215551 | PubTator, text mining | PubMed |
| Mechanisms underlying centriole stability. | J Biol Chem | 2025 | 41167311 | PubTator, text mining | PubMed |
| Polo-like kinase 4 (PLK4) as a therapeutic target in breast cancer. | Carcinogenesis | 2025 | 41092110 | PubTator, text mining | PubMed |
| High expression of polo-like kinase 4 predicts worse progression-free survival in diffuse large B cell lymphoma patients treated with R-CHOP. | World J Surg Oncol | 2025 | 41088205 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of indazole-based PLK4 inhibitors. | RSC Med Chem | 2025 | 41058932 | PubTator, text mining | PubMed |
| Does microtubule motor-mediated centrosomal dyshomeostasis confer chemoresistance in breast cancer? | J Mammary Gland Biol Neoplasia | 2025 | 41003863 | PubTator, text mining | PubMed |
| Polo-like Kinase 4: A Molecular Culprit in Skin Cancer Pathogenesis. | Cells | 2025 | 40940791 | PubTator, text mining | PubMed |
| Evodiamine induces centrosome amplification with subsequent G2/M cell cycle arrest in primary vascular smooth muscle cells. | Biochem Pharmacol | 2025 | 40935161 | PubTator, text mining | PubMed |
| Biomolecular phase separation in tumorigenesis: from aberrant condensates to therapeutic vulnerabilities. | Mol Cancer | 2025 | 40849651 | PubTator, text mining | PubMed |
| Dysregulated SASS6 expression promotes increased ciliogenesis and cell invasion phenotypes. | Life Sci Alliance | 2025 | 40825584 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of 5-chlorine-2-amino-pyrimidine derivatives as potent PLK4 inhibitors. | RSC Med Chem | 2025 | 40823488 | PubTator, text mining | PubMed |
| High-throughput virtual screening, identification and in vitro biological evaluation of novel inhibitors of PLK1 and NRP1. | J Enzyme Inhib Med Chem | 2025 | 40820676 | PubTator, text mining | PubMed |
| The PLK4 inhibitor RP-1664 demonstrates potent single-agent efficacy in neuroblastoma models through a dual mechanism of sensitivity. | Res Sq | 2025 | 40766251 | PubTator, text mining | PubMed |
| Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. | Bioact Mater | 2025 | 40761549 | PubTator, text mining | PubMed |
| Cough duration, energy and sound frequency in COVID-19 patients: the spectral analysis results. | BMC Pulm Med | 2025 | 40751248 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10733/papers?page=3